Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

The Global COVID‐19 Observatory and Resource Center for Childhood Cancer: A response for the pediatric oncology community by SIOP and St. Jude Global

Moreira, D. C., Sniderman, E., Mukkada, S. T., Chantada, G. L., Bhakta, N. H., Foster, W., Avula, M., Homsi, M. R., Faughnan, L., Happ, B., et al. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.28962 · Cited by 15

An extended state of uncertainty: A snap-shot of expressions of concern in neuroscience

da Silva, J. A. T., & Yamada, Y. (2021) · Current Research in Behavioral Sciences · doi:10.1016/j.crbeha.2021.100045 · Cited by 16

The COVID-19 Pandemic: A Health Crisis Managed or a Panic Response with Disastrous Future Consequences?

Luqmani, Y. A., & El‐Hashim, A. Z. (2021) · Medical Principles and Practice · doi:10.1159/000520258 · Cited by 16

Nanotechnology and COVID-19: quo vadis?

Tavares, J. L., Cavalcanti, I. D. L., Santos-Magalhães, N. S., & Nogueira, M. C. D. B. L. (2022) · Journal of Nanoparticle Research · doi:10.1007/s11051-022-05452-0 · Cited by 15

An editorial perspective on the infamous COVID-19 studies retracted by Lancet and NEJM

Sengupta, S. (2020) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1853_20 · Cited by 15

Treatment Effects in Randomized and Nonrandomized Studies of Pharmacological Interventions

Salcher‐Konrad, M., Nguyen, M., Savović, J., Higgins, J. P. T., & Naci, H. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.36230 · Cited by 15

Absence of relevant QT interval prolongation in not critically ill COVID-19 patients

Jiménez‐Jáimez, J., Ruiz, R. M., Bermúdez-Jiménez, F. J., Rubini-Costa, R., Ramírez-Taboada, J., Flores, P. I. G., Gallo-Padilla, L., García, J. D. M., García, C. M., Suárez, S. M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78360-9 · Cited by 14

Effect of Lockdown on Diabetes Care During the COVID-19 Pandemic: Result of a Telephone-Based Survey Among Patients Attending a Diabetic Clinic in Northern India

Verma, M., Sharma, P., Chaudhari, A., Sharma, M., & Kalra, S. (2021) · Cureus · doi:10.7759/cureus.18489 · Cited by 14

An overview on the current available treatment for COVID-19 and the impact of antibiotic administration during the pandemic

de Paula, H. D. S. C., Santiago, S. B., de Araújo, L. A., Pedroso, C. F., Marinho, T. A., Gonçalves, I. A. D. J., Santos, T. A. P., Pinheiro, R. S., de Oliveira, G. A., & Batista, K. D. A. (2021) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2021e11631 · Cited by 14

Off‐Label Use of Hydroxychloroquine in COVID‐19: Analysis of Reports of Suspected Adverse Reactions From the Italian National Network of Pharmacovigilance

Fallani, E., Cevenini, F., Lazzerini, P. E., Verdini, A., & Saponara, S. (2021) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2006 · Cited by 14

Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study

McKinnon, J. E., Wang, D. D., Zervos, M., Saval, M., Marshall-Nightengale, L., Kilgore, P. E., Pabla, P., Szandzik, E. G., Maksimowicz‐McKinnon, K., & O’Neill, W. W. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.12.343 · Cited by 14

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Moon, R. J., Reginster, J., Al‐Daghri, N. M., Thiyagarajan, J. A., Beaudart, C., Bruyère, O., Burlet, N., Chandran, M., da Silva, M. C., Conaghan, P. G., et al. (2023) · Osteoporosis International · doi:10.1007/s00198-023-06827-2 · Cited by 15

A false promise of COVID-19 ‘big’ health data? Health data integrity and the ethics and realities of Australia’s health information management practice

Robinson, K. M. (2020) · Health Information Management Journal · doi:10.1177/1833358320941190 · Cited by 14

Impact of COVID-19 Pandemic on the Psychological Status of Palestinian Adults in the West Bank, Palestine; A Cross-Sectional Study

Asmar, I., Naseef, H., Al-Shami, N. A., Jaghama, M., Abukhalil, A. D., Karsh, A. A., AlFayyah, F. A., & Dagher, R. M. (2021) · The Open Psychology Journal · doi:10.2174/1874350102114010227 · Cited by 14

Balancing Scientific Rigor With Urgency in the Coronavirus Disease 2019 Pandemic

Spec, A., & Schwartz, I. S. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa304 · Cited by 13

How fast is the peer-review process for orthopaedic publications related to the Covid-19 pandemic?

Khalifa, A. A., & Abdelaal, A. M. (2020) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2020.09.007 · Cited by 13

Implementation of documented and written informed consent for clinical trials of communicable diseases: Lessons learned, barriers, solutions, future directions identified during the conduct of a COVID-19 clinical trial

Woods, P. A., Flynn, M., Monach, P. A., Visnaw, K., Schiller, S., Holmberg, E. F., Leatherman, S. M., Ferguson, R. E., & Branch‐Elliman, W. (2021) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2021.100804 · Cited by 13

Importance of suppression and mitigation measures in managing COVID-19 outbreaksPreprint

Hochberg, M. (2020) · medRxiv · doi:10.1101/2020.03.31.20048835 · Cited by 13

COVID-19 and hydroxychloroquine: Is the wonder drug failing?

Paliani, U., & Cardona, A. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.06.002 · Cited by 13

Publication Metrics: Types, Utility, and Caveats

Misra, D. P. (2022) · Indian Journal of Rheumatology · doi:10.4103/0973-3698.364674 · Cited by 12

Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019

Schluenz, L., Ramos-Otero, G. P., & Nawarskas, J. J. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000329 · Cited by 12

Therapeutic interventions for COVID-19: a living overview of reviews

Khalili, M., Chegeni‬‬, M., Javadi, S., Farokhnia, M., Sharifi, H. P., & Karamouzian, M. (2020) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466620976021 · Cited by 12

How did COVID-19 affect medical and cardiology journals? A pandemic in literature

Venturelli, A., Vitolo, M., Albini, A., & Boriani, G. (2021) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001245 · Cited by 12

Traditional Chinese medicine for COVID-19 pandemic and emerging challenges: An online cross-sectional survey in China

Lu, C.-L., Zheng, R.-X., Xue, X., Zhang, X. W., Liu, X., Jin, X.-Y., Pu, F., Lan, H.-D., Fang, M., Kong, L., et al. (2021) · Integrative Medicine Research · doi:10.1016/j.imr.2021.100798 · Cited by 12

COVID-19-Related manuscripts: lag from preprint to publication

Drzymalla, E., Yu, W., Khoury, M. J., & GWINN, M. L. (2022) · BMC Research Notes · doi:10.1186/s13104-022-06231-9 · Cited by 12

“Warp Speed” Operations in the COVID-19 Pandemic

Norman, G. A. V. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.06.001 · Cited by 12

The trade-off dilemma in pharmacotherapy of COVID-19: systematic review, meta-analysis, and implications

Khan, S. A., Gionfriddo, M. R., Cortes-Penfield, N. W., Thunga, G., & Rashid, M. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1792884 · Cited by 12

Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection

Carafoli, E. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.09.128 · Cited by 13

Factores pronósticos en pacientes hospitalizados con diagnóstico de infección por SARS-CoV-2 en Bogotá, Colombia

Motta, J. C., Novoa, D., Gómez, C. C., Moreno, J. M., Vargas, L. P., Perez, J. H. B., Millán, H. A., & Arango, Á. I. (2020) · Biomédica · doi:10.7705/biomedica.5764 · Cited by 12

Barely sufficient practices in scientific computing

Lee, G., Bacon, S., Bush, I. J., Fortunato, L., Gavaghan, D. J., Lestang, T., Morton, C. E., Robinson, M. J., Rocca‐Serra, P., Sansone, S., et al. (2021) · Patterns · doi:10.1016/j.patter.2021.100206 · Cited by 12

Hydroxychloroquine Effects on TLR Signalling: Underexposed but Unneglectable in COVID-19

Veld, A. E. I. ‘., Jansen, M. A. A., Ciere, L. C. A., & Moerland, M. (2021) · Journal of Immunology Research · doi:10.1155/2021/6659410 · Cited by 12

The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment

Younis, N. K., Zareef, R. O., Maktabi, M. A., & Mahfouz, R. A. (2021) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2020.0227 · Cited by 12

Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study

Choi, M. J., Kang, M., Shin, S. Y., Noh, J. Y., Cheong, H. J., Kim, W. J., Jung, J., & Song, J. Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.10.062 · Cited by 11

A Road Map for Peer Review of Real-World Evidence Studies on Safety and Effectiveness of Treatments

Winterstein, A. G., Ehrenstein, V., Brown, J. S., Stürmer‎, T., & Smith, M. Y. (2023) · Diabetes Care · doi:10.2337/dc22-2037 · Cited by 11

Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter

Gupta, A., & Malviya, A. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138585 · Cited by 11

Essential medicine selection during the COVID-19 pandemic: Enabling access in uncharted territory

Leong, T. D. D., McGee, S., Gray, A., de Waal, R., Kredo, T., Cohen, K., Reubenson, G., Blockman, M., Nel, J. S., Maartens, G., et al. (2020) · South African Medical Journal · doi:10.7196/samj.2020.v110i11.15271 · Cited by 11

What have we learned from the first to the second wave of COVID-19 pandemic? An international survey from the ESCMID Study Group for Infection in the Elderly (ESGIE) group

Tiseo, G., Yahav, D., Paul, M., Tinelli, M., Gavazzi, G., Mussini, C., Prendki, V., & Falcone, M. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04377-1 · Cited by 11

Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: Reasoning about connections

Minetti, G. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110128 · Cited by 12

Therapeutic status of hydroxychloroquine in COVID-19: A review

Kaushal, S., Kaur, K., & Kaushal, I. G. (2020) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/joacp.joacp_313_20 · Cited by 11

Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials

Bokharee, N., Khan, Y. H., Khokhar, A., Mallhi, T. H., Alotaibi, N. H., & Rasheed, M. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1902805 · Cited by 11

Timeline from receipt to online publication of COVID-19 original research articlesPreprint

Barakat, A. F., Shokr, M., Ibrahim, J., Mandrola, J. M., & Elgendy, I. Y. (2020) · medRxiv · doi:10.1101/2020.06.22.20137653 · Cited by 11

Prioritizing clinical research studies during the COVID-19 pandemic: lessons from New York City

Gulick, R. M., Sobieszczyk, M. E., Landry, D. W., & Hollenberg, A. N. (2020) · Journal of Clinical Investigation · doi:10.1172/jci142151 · Cited by 10

Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta‐analysis

Gupta, T., Thakkar, P., Kalra, B., & Kannan, S. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2276 · Cited by 10

Changing the Culture on Data Management and Sharing: Getting Ready for the New NIH Data Sharing Policy

Martone, M. E., & Nakamura, R. (2022) · Harvard Data Science Review · doi:10.1162/99608f92.6650ce2b · Cited by 10

Poor statistical reporting: do we have a reason for concern? A narrative review and recommendations

Ordak, M. (2024) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000965 · Cited by 10

Marked Escalation in Journal Submissions During COVID-19 Pandemic

Nigrovic, L. E., & Napper, T. (2020) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2020.07.003 · Cited by 10

Pragmatic, adaptive clinical trials: Is 2020 the dawning of a new age?

Branch‐Elliman, W., Lehmann, L. S., Boden, W. E., Ferguson, R. E., & Monach, P. A. (2020) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2020.100614 · Cited by 10

Hydroxychloroquine and Coronavirus Disease 2019: A Systematic Review of a Scientific Failure

Rakedzon, S., Khoury, Y., Rozenberg, G., & Neuberger, A. (2020) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10416 · Cited by 11

Hydroxychloroquine and maintenance immunosuppression use in kidney transplant recipients: Analysis of linked US registry and claims data

Lentine, K. L., Lam, N. N., Çalışkan, Y., Alhamad, T., Xiao, H., Schnitzler, M. A., Chang, S., Axelrod, D. A., Segev, D. L., McAdams‐DeMarco, M., et al. (2020) · Clinical Transplantation · doi:10.1111/ctr.14118 · Cited by 10

Journal Retraction Rates and Citation Metrics: An Ouroboric Association?

Nagella, A. B., & Madhugiri, V. S. (2020) · Cureus · doi:10.7759/cureus.11542 · Cited by 10

Characteristics and outcomes of hospitalised adults with COVID-19 in a Global Health Research Network: a cohort study

Zhu, J., Wei, Z., Suryavanshi, M. S., Chen, X., Xia, Q., Jiang, J. Z., Ayodele, O. A., Bradbury, B. D., Brooks, C. G., Brown, C., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-051588 · Cited by 10

A Focus on the Nowadays Potential Antiviral Strategies in Early Phase of Coronavirus Disease 2019 (Covid-19): A Narrative Review

Monari, C., Gentile, V., Camaioni, C., Marino, G., Coppola, N., & Vanvitelli COVID-19 group (2020) · Life · doi:10.3390/life10080146 · Cited by 9

Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019

Zhu, C., Sun, B., Zhang, X., & Zhang, B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01327 · Cited by 9

The Fragility of Scientific Rigour and Integrity in “Sped up Science”: Research Misconduct, Bias, and Hype and in the COVID-19 Pandemic

Lipworth, W. L., Kerridge, I., Stewart, C. L., Silva, D. A. S., & Upshur, R. E. G. (2023) · Journal of Bioethical Inquiry · doi:10.1007/s11673-023-10289-w · Cited by 9

Therapeutic strategies against COVID-19.

Esposito, S., Gnocchi, M., Gagliardi, M., Affanni, P., Veronesi, L., Colucci, M. E., Neglia, C., Argentiero, A., & Principi, N. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i3.10450 · Cited by 9

Outcomes and Laboratory and Clinical Findings of Asthma and Allergic Patients Admitted With Covid-19 in a Spanish University Hospital

García-Menaya, J. M., Cordobés-Durán, C., Rangel-Mayoral, J. F., García‐Martín, E., & Agúndez, J. A. G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.570721 · Cited by 9

COVID-19 Clinical Trials Registered Worldwide for Drug Intervention: An Overview and Characteristic Analysis

Wang, B., Lai, J., Yan, X., Jin, F., Yi, B., An, C., Li, Y., & Yao, C. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s281700 · Cited by 9

How the COVID-19 Pandemic Impacts Lives of Life Scientists

Scharf, R. E. (2021) · Hämostaseologie · doi:10.1055/a-1339-8671 · Cited by 9

Data Pseudonymization in a Range That Does Not Affect Data Quality: Correlation with the Degree of Participation of Clinicians

Shin, S.-Y., & Kim, H. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e299 · Cited by 9

Reproducible Research Practices in the Plastic Surgery Literature

Ascha, M., Katabi, L., Stevens, E., Gatherwright, J., & Vassar, M. B. (2022) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000008956 · Cited by 9

Modeling Trust in Enterprise Architecture: A Pattern Language for ArchiMate

Amaral, G. C. M., Sales, T. P., Guizzardi, G., Almeida, J. P. A., & Porello, D. (2020) · Lecture notes in business information processing · doi:10.1007/978-3-030-63479-7_6 · Cited by 9

Breakthrough healthcare technologies in the COVID-19 era: a unique opportunity for cardiovascular practitioners and patients

Raffaele, N. U. D. I., Campagna, M., PARMA, A., Andrea, N. U. D. I., & Biondi‐Zoccai, G. (2021) · Panminerva Medica · doi:10.23736/s0031-0808.20.04188-9 · Cited by 9

Data transparency: “Nothing has changed since Tamiflu”

Wise, J. (2020) · BMJ · doi:10.1136/bmj.m2279 · Cited by 9

Towards replicability and sustainability in cancer research

Grimes, D. R. (2024) · BJC Reports · doi:10.1038/s44276-024-00090-6 · Cited by 9

Post-COVID-19 Emerging Challenges and Predictions on People, Process, and Product by Metaheuristic Deep Learning Algorithm

Ganesan, V., Rajarajeswari, P., Govindaraj, V., Prakash, K. B., & Naren, J. (2021) · Advances in intelligent systems and computing · doi:10.1007/978-981-15-9516-5_24 · Cited by 8

Bronchoalveolar lavage-detected SARS-CoV-2 infection in presence of serial negative nasopharyngeal swabs: a case report

Caci, G., Minervini, F., Fechner, C., Roos, J. E., Obermann, E. C., & Azzola, A. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-4307 · Cited by 8

Ten simple rules for socially responsible science

Zivony, A., Kardosh, R., Timmins, L., & Reggev, N. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010954 · Cited by 9

Scientific integrity in biomedical research is a global problem

Paryzhak, S., & Vari, S. G. (2024) · The Ukrainian Biochemical Journal · doi:10.15407/ubj96.02.012 · Cited by 8

Statistical Opportunities to Accelerate Development for COVID-19 Therapeutics

Natanegara, F., Zariffa, N. M.-D., Buenconsejo, J., Liao, R., Cooner, F., Lakshminarayanan, D., Ghosh, S., Schindler, J. S., & Gamalo, M. (2020) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2020.1865195 · Cited by 8

Panorama de pesquisas com seres humanos sobre covid-19 no Brasil

Castro‐Silva, I. I., & Maciel, J. A. C. (2020) · Revista Bioética · doi:10.1590/1983-80422020284429 · Cited by 8

Robotic Abdominal Surgery and COVID-19: A Systematic Review of Published Literature and Peer-Reviewed Guidelines during the SARS-CoV-2 Pandemic

Fleming, C., Fullard, A. C., Croghan, S., Pellino, G., & Pata, F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11112957 · Cited by 8

Factors associated with the speed and scope of diffusion of COVID-19 therapeutics in a nationwide healthcare setting: a mixed-methods investigation

La, J., Fillmore, N. R., Do, N., Brophy, M. T., Monach, P. A., & Branch‐Elliman, W. (2022) · Health Research Policy and Systems · doi:10.1186/s12961-022-00935-x · Cited by 8

Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century

Sanghai, N., Shafiq, K., & Tranmer, G. K. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520999200824103803 · Cited by 8

Surging publications on the COVID-19 pandemic

Li, G., Zhou, Y., Ji, J., Liu, X., Jin, Q., & Zhang, L. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.09.010 · Cited by 8

Changes in Social Media Impact of the Radiological Literature During the Covid-19 Pandemic

Patel, V. N., Li, C. H., Acharya, J., Lerner, A., & Rajamohan, A. (2020) · Academic Radiology · doi:10.1016/j.acra.2020.11.002 · Cited by 8

Antiviral optical techniques as a possible novel approach to COVID-19 treatment

Moshfegh, F., Khosraviani, F., Moghaddasi, N., Limoodi, S. F. S. J., & Boluki, E. (2021) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545821300020 · Cited by 8

'Any and every cure for COVID-19': an imminent epidemic of alternative remedies amidst the pandemic?

Eboreime, E., Iwu, C. J., & Banke-Thomas, A. O. (2020) · Pan African Medical Journal · doi:10.11604/pamj.supp.2020.35.2.24728 · Cited by 8

A dossier on COVID-19 chronicle

Rufaida, R., Mahmood, T., Kedwai, I., Ahsan, F., Shamim, A., Shariq, M., & Parveen, S. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2020-0511 · Cited by 8

A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research

Zahoránszky-Köhalmi, G., Siramshetty, V. B., Kumar, P., Gurumurthy, M., Grillo, B., Mathew, B., Metaxatos, D., Backus, M., Mierzwa, T., Simon, R., et al. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00431 · Cited by 8

Treatment of COVID-19 Patients Post-Bariatric Surgery: Issues for Consideration

Azran, C., Porat, D., Dahan, A., & Dicker, D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092827 · Cited by 7

Fraud in Medical Publications

Nato, C. G., & Bilotta, F. (2024) · Anesthesiology Clinics · doi:10.1016/j.anclin.2024.02.004 · Cited by 7

“Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors – A survey"

Gangopadhyay, K. K., Sinha, B., & Ghosal, S. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.07.040 · Cited by 7

The Most Widely Disseminated COVID-19-Related Scientific Publications in Online Media: A Bibliometric Analysis of the Top 100 Articles with the Highest Altmetric Attention Scores

Moon, J. Y., Yoon, D. Y., Hong, J. H., Lim, K. J., Baek, S., Seo, Y. L., & Yun, E. J. (2021) · Healthcare · doi:10.3390/healthcare9020239 · Cited by 7

Apophenia and anesthesia: how we sometimes change our practice prematurely

Hanson, N. A., Lavallee, M. B., & Thiele, R. H. (2021) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-021-02005-2 · Cited by 8

The Rise and Fall of Hydroxychloroquine with the COVID-19 Pandemic: Narrative Review of Selected Data

Tang, W., Khalili, L., Giles, J. T., Gartshteyn, Y., Kapoor, T. M., Guo, C., Chen, T., Theodore, D., & Askanase, A. (2021) · Rheumatology and Therapy · doi:10.1007/s40744-021-00315-x · Cited by 7

Impact of COVID ‐19 on Otolaryngology Literature

Chillakuru, Y. R., Gerhard, E. F., Shim, T., Selesnick, S. H., Lustig, L. R., Krouse, J. H., Hanna, E. Y., Smith, T. L., Fisher, E. W., Kerschner, J. E., et al. (2021) · The Laryngoscope · doi:10.1002/lary.29902 · Cited by 7

Failed clinical trials on COVID-19 acute respiratory distress syndrome in hospitalized patients: common oversights and streamlining the development of clinically effective therapeutics

Battaglini, D., Cruz, F. F., Robba, C., Pelosi, P. P., & Rocco, P. R. M. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2120801 · Cited by 7

Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19

Sandercock, P. A., Darbyshire, J. H., DeMets, D. L., Fowler, R., Lalloo, D. G., Munavvar, M., Staplin, N., Warris, A., Wittes, J., & Emberson, J. (2022) · Trials · doi:10.1186/s13063-022-06824-6 · Cited by 7

Lessons Learned from a Global Perspective of Coronavirus Disease-2019

Kaul, V., Chahal, J., Schrarstzhaupt, I. N., Geduld, H. I., Shen, Y., Cecconi, M., Siqueira, A. M., Markoski, M. M., & Kawano-Dourado, L. B. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.11.020 · Cited by 7

Epimeteo y Prometeo en los tiempos del COVID-19

Young, P. (2020) · Fronteras en Medicina · doi:10.31954/rfem/202002/0075-0079 · Cited by 7

Patient-reported outcomes of neurologic and neuropsychiatric symptoms in mild COVID-19: a prospective cohort study

Ganesh, A., Rosentreter, R. E., Chen, Y., Mehta, R., McLeod, G. A., Wan, M. M., Krett, J. D., Mahjoub, Y., Lee, A. S., Schwartz, I. S., et al. (2023) · CMAJ Open · doi:10.9778/cmajo.20220248 · Cited by 7

An expression of concern on research during the Covid-19 pandemic

Calcaterra, G., Bassareo, P. P., Nodari, S., Barillà, F., Franco, A. D., & Romeo, F. (2020) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001074 · Cited by 7

Bringing evidence from press release to the clinic in the era of COVID-19

McMahon, J. H., Lydeamore, M., & Stewardson, A. J. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa506 · Cited by 7

Littérature médicale et COVID-19 : comment trois articles ont influencé les médias et la décision publique en France

Péretz, F., Bonini-Vuillod, J., Grivaux, M., Duracinský, M., & Chassany, O. (2021) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2021.03.010 · Cited by 7

In silico Exploration of Interactions Between Potential COVID-19 Antiviral Treatments and the Pore of the hERG Potassium Channel—A Drug Antitarget

Al‐Moubarak, E., Sharifi, M., & Hancox, J. C. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.645172 · Cited by 7

Old drugs, new tricks: leveraging known compounds to disrupt coronavirus-induced cytokine storm

Richman, S., Lyman, C. A., Nesterova, A. P., Yuryev, A., Morris, M., Cao, H., Cheadle, C., Skuse, G. R., & Broderick, G. (2022) · npj Systems Biology and Applications · doi:10.1038/s41540-022-00250-9 · Cited by 7

Treatment Armamentarium of COVID-19: Evolving Strategies and Evidence So Far

Dhampalwar, S., Saigal, S., & Soin, A. S. (2020) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2020.07.001 · Cited by 7

Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States

Rhodes, N. J., Dairem, A., Moore, W. J., Shah, A., Postelnick, M. J., Badowski, M. E., Michienzi, S. M., Borkowski, J., Polisetty, R. S., Fong, K., et al. (2021) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaa426 · Cited by 7

Retraction of Studies on Potential Drug Therapies for COVID-19: A Call for Reliability and Scientific Integrity

Guzmán-Prado, Y. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.06.061 · Cited by 7

On the Importance of Data Transparency

Callaghan, S. (2020) · Patterns · doi:10.1016/j.patter.2020.100070 · Cited by 6

News in Brief

Passi, G. R. (2020) · Indian Pediatrics · doi:10.1007/s13312-020-1908-5

Learning from a retraction

The Editors of the Lancet Group (2020) · The Lancet · doi:10.1016/s0140-6736(20)31958-9 · Cited by 50

Data from Mehra et al. (2020-05-29), "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis"

Mehra, M. R., Desai, S. S., Ruschitzka, F. T., & Patel, A. N. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.3870966

Zweifelhafte COVID-Studien – die Grenzen des Peer Reviews und der Nutzen von Twitter

Nößler, D., & Scherer, M. (2020) · EvidenzUpdate · doi:10.69156/pod.001/2020.06.00035